Baroda BNP Paribas Health and Wellness Fund Regular Growth

Baroda BNP Paribas Health and Wellness Fund Regular Growth is an equity fund. This fund was started on 27 June, 2025. The fund is managed by Sanjay Chawla. The fund could potentially beat inflation in the long-run.

1. Baroda BNP Paribas Health and Wellness Fund Regular Growth has ₹0 Cr worth of assets under management (AUM) as on Jul 2025 and is more than category average.
2. The fund has an expense ratio 0.
   

Baroda BNP Paribas Health and Wellness Fund Regular Growth has given a CAGR return of -0.28% since inception.

Baroda BNP Paribas Health and Wellness Fund Regular Growth has allocated its funds majorly in Cash Equivalent, Health. Its top holdings are Divi's Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Fortis Healthcare Ltd, Cipla Ltd, Laurus Labs Ltd

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Minimum investment for lump sum payment is INR 1000.00 and for SIP is INR 500.00. Baroda BNP Paribas Health and Wellness Fund Regular Growth has no lock in period.